600 related articles for article (PubMed ID: 32503812)
1. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.
Wu J; Huang J; Zhu G; Wang Q; Lv Q; Huang Y; Yu Y; Si X; Yi H; Wang C; Liu Y; Xiao H; Zhou Q; Liu X; Yang D; Guan X; Li Y; Peng S; Sung J; Xiao H
BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32503812
[TBL] [Abstract][Full Text] [Related]
2. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.
Zhang J; Kong W; Xia P; Xu Y; Li L; Li Q; Yang L; Wei Q; Wang H; Li H; Zheng J; Sun H; Xia W; Liu G; Zhong X; Qiu K; Li Y; Wang H; Wang Y; Song X; Liu H; Xiong S; Liu Y; Cui Z; Hu Y; Chen L; Pan A; Zeng T
Front Endocrinol (Lausanne); 2020; 11():525. PubMed ID: 32754119
[No Abstract] [Full Text] [Related]
3. Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study.
Chang MC; Hwang JM; Jeon JH; Kwak SG; Park D; Moon JS
Endocrinol Metab (Seoul); 2020 Sep; 35(3):595-601. PubMed ID: 32842719
[TBL] [Abstract][Full Text] [Related]
4. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.
Wang S; Ma P; Zhang S; Song S; Wang Z; Ma Y; Xu J; Wu F; Duan L; Yin Z; Luo H; Xiong N; Xu M; Zeng T; Jin Y
Diabetologia; 2020 Oct; 63(10):2102-2111. PubMed ID: 32647915
[TBL] [Abstract][Full Text] [Related]
5. J-shaped association between fasting blood glucose levels and COVID-19 severity in patients without diabetes.
Zhu B; Jin S; Wu L; Hu C; Wang Z; Bu L; Sun H; Wang X; Qu S; Chen D
Diabetes Res Clin Pract; 2020 Oct; 168():108381. PubMed ID: 32853687
[TBL] [Abstract][Full Text] [Related]
6. Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China.
Wu J; Huang J; Zhu G; Liu Y; Xiao H; Zhou Q; Si X; Yi H; Wang C; Yang D; Chen S; Liu X; Liu Z; Wang Q; Lv Q; Huang Y; Yu Y; Guan X; Li Y; Nirantharakumar K; Cheng K; Peng S; Xiao H
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32880390
[TBL] [Abstract][Full Text] [Related]
7. Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection.
Foy BH; Carlson JCT; Reinertsen E; Padros I Valls R; Pallares Lopez R; Palanques-Tost E; Mow C; Westover MB; Aguirre AD; Higgins JM
JAMA Netw Open; 2020 Sep; 3(9):e2022058. PubMed ID: 32965501
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.
Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M
Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977
[No Abstract] [Full Text] [Related]
9. Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study.
Fumagalli C; Rozzini R; Vannini M; Coccia F; Cesaroni G; Mazzeo F; Cola M; Bartoloni A; Fontanari P; Lavorini F; Marcucci R; Morettini A; Nozzoli C; Peris A; Pieralli F; Pini R; Poggesi L; Ungar A; Fumagalli S; Marchionni N
BMJ Open; 2020 Sep; 10(9):e040729. PubMed ID: 32978207
[TBL] [Abstract][Full Text] [Related]
10. Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: A retrospective study.
Li Y; Han X; Alwalid O; Cui Y; Cao Y; Liu J; Gu J; Wang L; Fan Y; Shi H
Diabetes Res Clin Pract; 2020 Aug; 166():108299. PubMed ID: 32623030
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.
Shi Q; Zhang X; Jiang F; Zhang X; Hu N; Bimu C; Feng J; Yan S; Guan Y; Xu D; He G; Chen C; Xiong X; Liu L; Li H; Tao J; Peng Z; Wang W
Diabetes Care; 2020 Jul; 43(7):1382-1391. PubMed ID: 32409504
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Glucose Levels in Patients Hospitalized With COVID-19 During the First Phase of This Pandemic in West Texas.
Rao S; Ali K; Dennis J; Berdine G; Test V; Nugent K
J Prim Care Community Health; 2020; 11():2150132720958533. PubMed ID: 32924762
[TBL] [Abstract][Full Text] [Related]
13. Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study.
Sadhu AR; Serrano IA; Xu J; Nisar T; Lucier J; Pandya AR; Patham B
J Diabetes Sci Technol; 2020 Nov; 14(6):1065-1073. PubMed ID: 33063556
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19.
Berger JS; Kunichoff D; Adhikari S; Ahuja T; Amoroso N; Aphinyanaphongs Y; Cao M; Goldenberg R; Hindenburg A; Horowitz J; Parnia S; Petrilli C; Reynolds H; Simon E; Slater J; Yaghi S; Yuriditsky E; Hochman J; Horwitz LI
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2539-2547. PubMed ID: 32840379
[TBL] [Abstract][Full Text] [Related]
15. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19.
Stefanini GG; Chiarito M; Ferrante G; Cannata F; Azzolini E; Viggiani G; De Marco A; Briani M; Bocciolone M; Bragato R; Corrada E; Gasparini GL; Marconi M; Monti L; Pagnotta PA; Panico C; Pini D; Regazzoli D; My I; Kallikourdis M; Ciccarelli M; Badalamenti S; Aghemo A; Reimers B; Condorelli G;
Heart; 2020 Oct; 106(19):1512-1518. PubMed ID: 32817312
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in hospitalized patients diagnosed with SARS-CoV-2 infection, Bogotá, Colombia.
Motta JC; Novoa DJ; Gómez CC; Moreno JM; Vargas L; Pérez J; Millán H; Arango ÁI
Biomedica; 2020 Oct; 40(Supl. 2):116-130. PubMed ID: 33152195
[TBL] [Abstract][Full Text] [Related]
18. Serum Cystatin C and Coronavirus Disease 2019: A Potential Inflammatory Biomarker in Predicting Critical Illness and Mortality for Adult Patients.
Chen D; Sun W; Li J; Wei B; Liu W; Wang X; Song F; Chen L; Yang J; Yu L
Mediators Inflamm; 2020; 2020():3764515. PubMed ID: 33061826
[TBL] [Abstract][Full Text] [Related]
19. Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China.
Liu X; Zheng X; Liu B; Wu M; Zhang Z; Zhang G; Su X
Aging (Albany NY); 2020 Jul; 12(13):12432-12440. PubMed ID: 32628642
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study.
Coppelli A; Giannarelli R; Aragona M; Penno G; Falcone M; Tiseo G; Ghiadoni L; Barbieri G; Monzani F; Virdis A; Menichetti F; Del Prato S;
Diabetes Care; 2020 Oct; 43(10):2345-2348. PubMed ID: 32788285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
